CELG News | Celgene Corp Articles

Results 51 - 60 of 516 : Previous 2 3 4 5 6 7 8 9 10 Next

International Investing | June 10, 2011

Could Teva Pharmaceutical Score You 100% Returns?

Is it high time to add Teva's stock to your portfolio?

Investing | June 08, 2011

High-Speed Shareholder Democracy

Shareowner rights are no longer on dial-up.

Investing | June 08, 2011

This Just In: Upgrades and Downgrades

Oppenheimer opts to buy Aeterna Zentaris.

High-Growth Investing | June 06, 2011

Big Pharma Tackles Lung Cancer; Biotech Helping, Too

A big underserved market.

High-Growth Investing | May 31, 2011

Profit From This Growing Drug Trend

Cancer drugs press on.

Value Investing | May 29, 2011

The 10 Best Values in Pharma and Biotech

How to avoid the low-growth, high-risk value trap.

Investing | May 25, 2011

Celgene's Management Is Creating Value

What EVA momentum shows us about the folks running Celgene.

High-Growth Investing | May 23, 2011

Does Amgen Deserve a Spot in Your Portfolio?

A quick check of the numbers should help get us started.

ETFs | May 20, 2011

Beware These "Very Attractive" ETFs

There are some big red flags here.

High-Growth Investing | May 19, 2011

Is Celgene's Stock Cheap by the Numbers?

Let's take a look.

Results 51 - 60 of 516 : Previous 2 3 4 5 6 7 8 9 10 Next